Research and Markets: Global Cholera Therapeutics Pipeline Review 2014 - 5 Drug Profiles From 3 Companies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/94cj3g/cholera) has announced the addition of the "Cholera - Pipeline Review, H2 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Cholera, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cholera and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Napo Pharmaceuticals, Inc.
  • PaxVax
  • Beijing Minhai Biotechnology Co., Ltd

Drug Profiles

  • crofelemer DR
  • PXVX-0200
  • Trivalent Cholera Vaccine
  • AKT-10082
  • Peptide for Cholera and Guillain-Barre Syndrome

For more information visit http://www.researchandmarkets.com/research/94cj3g/cholera

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases